Author:
Louter Mark A.,Pelzer Nadine,de Boer Irene,Kuijvenhoven Babette E.C.,van Oosterhout Willebrordus P.J.,van Zwet Erik W.,Ferrari Michel D.,Terwindt Gisela M.
Abstract
Objective:To determine the prevalence of depression and determinants associated with depression in a large population of hemiplegic migraine (HM) patients.Methods:We conducted a cross-sectional, validated questionnaire study among 89 well-defined HM patients and 235 headache-free controls. The prevalence of lifetime depression and its relation to migraine characteristics was assessed.Results:HM patients had increased odds for lifetime depression (odds ratio 3.73, 95% confidence interval 2.18–6.38) compared with controls. Use of acute antimigraine medication was associated with lifetime depression.Conclusions:Depression is part of the monogenic hemiplegic migraine phenotype. Further studies are needed to elucidate the pathophysiologic role of HM genes in comorbid depression. For now, clinicians should take comorbid depression into consideration when starting prophylactic treatment of HM.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献